Depressive disorders in cardiology practice : Diagnosis and treatment

Depressive disorders in cardiology practice : Diagnosis and treatment

Show other versions (1)

The paper discusses the problems of correct diagnosis and rational pharmacotherapy of depressive disorders in patients with cardiovasculardiseases frequently found by practical cardiologists and therapists.

Bibliographic Details
Main Author:	F. Yu. Kopylov
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	depression cardiovascular diseases selective serotonin reuptake inhibitors
Online Access:	https://klinitsist.abvpress.ru/Klin/article/view/33

Similar Items

Depressive disorders in cardiology practice : Diagnosis and treatment
by: F. Yu. Kopylov
Published: (2014-07-01)

Molecular mechanism of noradrenaline during the stress-induced major depressive disorder
by: Kenjiro Seki, et al.
Published: (2018-01-01)

Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study
by: Robyn P. Thom, et al.
Published: (2021-09-01)

An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
by: Kuga A, et al.
Published: (2017-08-01)

A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
by: Zhong Z, et al.
Published: (2017-11-01)

Selective serotonin reuptake inhibitors and cardiovascular events: A systematic review
by: Mohammad Hassan Nezafati, et al.
Published: (2016-01-01)

Assessment of Hyperprolactinemia in Drug Naive Patients with Depression
by: Subhendu Datta, et al.
Published: (2021-04-01)

Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
by: Tommaso Cassano, et al.
Published: (2019-09-01)

Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression
by: Hye-Geum Kim, et al.
Published: (2019-09-01)

Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
by: Maximilian Gahr, et al.
Published: (2020-02-01)

The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
by: McIntyre RS
Published: (2017-11-01)

Changes in EEG indices and serotonin concentrations in depression and anxiety disorders
by: I. V. Kichuk, et al.
Published: (2016-11-01)

The relation between immunologic variables and symptom factors in patients with major depressive disorder
by: Yang-Whan Jeon, et al.
Published: (2018-07-01)

A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial
by: George Salaminios, et al.
Published: (2017-10-01)

Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case report
by: Marzieh Azizi, et al.
Published: (2019-09-01)

Effects of three months treatment with sertraline on intraocular pressure and cup-to-disc ratio in patients with anxiety disorders/mixed anxiety and depressive disorder/major depressive disorder and without underlying eye disease
by: Narjes Hendouei, et al.
Published: (2017-09-01)

Selective serotonin reuptake inhibitors-paroxetine induced galactorrhea in a case of somatoform disorder
by: Ajay Halder, et al.
Published: (2015-01-01)

Major Depressive Disorder Complicated with Spinocerebellar Ataxia: Report of 2 Cases
by: Nagahisa Okamoto, et al.
Published: (2010-05-01)

Suicidality and Suicide Attempt in a Young Female on Long-Term Sertraline Treatment
by: Ranjita Santra, et al.
Published: (2012-01-01)

Chirality of Modern Antidepressants: An Overview
by: Monica Budău, et al.
Published: (2017-12-01)

Depression and Psychological Distress as Risk Factors for Stroke and Worse Stroke Recovery: Clinical Implications and Therapeutic Options
by: Kerstin Sander, et al.
Published: (2014-07-01)

Effect of Depression and Antidepressants on Sexual Dysfunction in Men with Diabetes: A National Population-Based Cohort Study
by: Chung PL, et al.
Published: (2020-04-01)

Learning from Negative Feedback in Patients with Major Depressive Disorder is Attenuated by SSRI Antidepressants
by: Mohammad M. Herzallah, et al.
Published: (2013-09-01)

Clinical description of affective disorders and efficiency of antidepressant therapy
by: E. V. Lebedeva, et al.
Published: (2018-12-01)

A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
by: Cui YH, et al.
Published: (2016-07-01)

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
by: Azmeraw T. Amare, et al.
Published: (2018-03-01)

Metabolic Syndrome and Cardiovascular Disease Risk in patients with Depressive disorder on Antidepressive Medication
by: Bhavana Singhal, et al.
Published: (2018-09-01)

Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial
by: Nishank Jain, et al.
Published: (2019-10-01)

Effect of Donepezil on Cognitive Disorders Due to the Selective Serotonin Reuptake Inhibitors in the Patients with Major Depressive Disorder
by: Fatemeh Hosseini, et al.
Published: (2020-01-01)

Chronic antidepressant treatment accelerates kindling epileptogenesis in rats
by: Lisa Cardamone, et al.
Published: (2014-03-01)

Effects of zinc supplementation in patients with major depression: a randomized clinical trial.
by: Elham Ranjbar, et al.
Published: (2013-06-01)

Effects of Zinc Supplementation in Patients with Major Depression: A Randomized Clinical Trial
by: Elham Ranjbar, et al.
Published: (2013-06-01)

Alteration of transthyretin and thyroxine-binding globulin in major depressive disorder: multiple reaction monitoring-based proteomic analysis
by: Hye In Woo, et al.
Published: (2021-01-01)

PREMATURE EJACULATION: CURRENT ASPECTS ON DIAGNOSIS AND TREATMENT. INTERDISCIPLINARY UROLOGICAL CONCILIUM
by: O. B. Zhukov, et al.
Published: (2018-08-01)

Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study
by: Yuan H, et al.
Published: (2019-04-01)

Intense suicidal thoughts and self-harm following escitalopram treatment
by: Farooq Khan, et al.
Published: (2011-01-01)

Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder
by: Reem Rafik Alolaby, et al.
Published: (2020-04-01)

Refining the clinical features of serotonin syndrome: A prospective observational study of 45 patients
by: Sanjay Prakash, et al.
Published: (2019-01-01)

Review of sexual dysfunction due to selective serotonin reuptake inhibitors
by: P Srilakshmi, et al.
Published: (2012-01-01)

Paroxetine Induced Akathisia: Necessity for Rational Use
by: Maryam Mousavi, et al.
Published: (2019-07-01)